Company Overview
About Endogenex
Endogenex is a medical device company headquartered in New Hope, Minnesota, developing endoscopic therapies for metabolic diseases. Its flagship product, the ReCET (Re-Cellularization via Electroporation Therapy) System, uses a catheter-based approach to deliver controlled electrical pulses to the duodenal lining. This non-surgical procedure remodels the duodenal epithelium — the tissue layer believed to play a key role in insulin resistance and glucose regulation — restoring more normal metabolic signaling without removing or bypassing anatomy.
Business Model & Competitive Advantage
The company raised a $25M Series B in 2024, building on earlier capital rounds and grant funding. Endogenex has completed European clinical investigations of the ReCET System, with trial data demonstrating meaningful improvements in glycemic control — including participants achieving drug-free diabetes remission in combination with a dietary protocol. These results have driven interest from gastroenterologists and endocrinologists seeking durable, minimally invasive alternatives to GLP-1 medications and metabolic surgery (such as gastric bypass) for patients with Type 2 diabetes.
Competitive Landscape 2025–2026
Endogenex is pursuing CE Mark in Europe and working toward US FDA investigational device exemption (IDE) trials. The company's approach targets the large and growing population of Type 2 diabetes patients who are not adequately controlled on medication, not candidates for bariatric surgery, or seeking a non-pharmacological option. Endogenex competes and potentially complements therapies in the procedural metabolic disease space, positioning ReCET as an earlier-line, repeatable intervention.
Frequently Asked Questions
Similar Brands
Oracle Health
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
PointClickCare
PointClickCare is North America's leading cloud-based software platform for the long-term and post-acute care (LTPAC) market, headquartered in Mississauga, Ontario, Canada. Founded in 1999, the compan
CoverMyMeds
CoverMyMeds is the largest prior authorization platform in the United States, operating a network that connects more than 750,000 providers, 75,000 pharmacies, and virtually all payers to streamline t
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
Compare Endogenex with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Endogenex? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Endogenex Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Endogenex vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →